FMC Reports $106 Million Revenue in Q3 2026 as Commercial Actions Drive $639 Million Impact
FMC Corporation reported Q3 2026 revenue of $106M, down 80% YoY, due to commercial actions impacting $639M. Excluding India and these actions, revenue was $745M, down 22% YoY. The company reported a GAAP net loss of $2.07B, with adjusted EBITDA at -$559M. FMC lowered its Q4 and full-year 2026 outlook, citing weaker demand and pricing pressures.
How this was made
The 30-second read
Why it matters
The earnings miss and lowered guidance are likely to trigger a sell‑off, with sector peers potentially affected.
Market read
The large revenue decline, significant loss, and negative outlook make this a high‑impact earnings release for FMC and its sector.
What to watch
The $500M rebate transition may stabilize cash flows long‑term, and the company’s focus on direct‑to‑grower sales in Brazil could offset short‑term weakness.
Background
FMC Corp, a US‑listed agricultural chemicals producer, released its Q3 2026 earnings and updated its full‑year outlook.
Ticker impact
FMC reported Q3 2026 revenue of $106M, an 80% decline, a $2.07B net loss and lowered full‑year outlook to negative adjusted EBITDA.
downward pressure as investors price in the large loss and reduced outlook
The company posted a massive revenue drop, a $2.07B loss and revised full‑year adjusted EBITDA to a negative range, which historically triggers sell‑offs.
Market effects
Agricultural chemicals sector may see broader pressure as FMC's inventory‑driven pricing actions signal demand weakness.
North America and Latin America revenues fell sharply, potentially weighing on regional agribusiness stocks.
FMC's guidance cut could influence global commodity‑linked equities and farm‑input investors.
Counterpoint
If FMC's inventory adjustments succeed, margins could improve in 2027, offering a buying opportunity at depressed prices.
Key entities
- companyFMC Corp
US‑listed agricultural chemicals manufacturer (ticker FMC).
